Literature DB >> 17382885

Programmed anuclear cell death delimits platelet life span.

Kylie D Mason1, Marina R Carpinelli, Jamie I Fletcher, Janelle E Collinge, Adrienne A Hilton, Sarah Ellis, Priscilla N Kelly, Paul G Ekert, Donald Metcalf, Andrew W Roberts, David C S Huang, Benjamin T Kile.   

Abstract

Platelets are anuclear cytoplasmic fragments essential for blood clotting and wound healing. Despite much speculation, the factors determining their life span in the circulation are unknown. We show here that an intrinsic program for apoptosis controls platelet survival and dictates their life span. Pro-survival Bcl-x(L) constrains the pro-apoptotic activity of Bak to maintain platelet survival, but as Bcl-x(L) degrades, aged platelets are primed for cell death. Genetic ablation or pharmacological inactivation of Bcl-x(L) reduces platelet half-life and causes thrombocytopenia in a dose-dependent manner. Deletion of Bak corrects these defects, and platelets from Bak-deficient mice live longer than normal. Thus, platelets are, by default, genetically programmed to die by apoptosis. The antagonistic balance between Bcl-x(L) and Bak constitutes a molecular clock that determines platelet life span: this represents an important paradigm for cellular homeostasis, and has profound implications for the diagnosis and treatment of disorders that affect platelet number and function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17382885     DOI: 10.1016/j.cell.2007.01.037

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  390 in total

1.  Platelet storage and transfusions: new concerns associated with an old therapy.

Authors:  Julie Sahler; Katie Grimshaw; Sherry L Spinelli; Majed A Refaai; Richard P Phipps; Neil Blumberg
Journal:  Drug Discov Today Dis Mech       Date:  2011-07-20

2.  Platelet senescence and phosphatidylserine exposure.

Authors:  Swapan Kumar Dasgupta; Eduardo Rios Argaiz; Jose Emmanel Chedid Mercado; Hector Omar Elizondo Maul; Jorge Garza; Ana Bety Enriquez; Hanan Abdel-Monem; Anthony Prakasam; Michael Andreeff; Perumal Thiagarajan
Journal:  Transfusion       Date:  2010-10-04       Impact factor: 3.157

3.  miR-125b and miR-155 contribute to BCL2 repression and proliferation in response to CD40 ligand (CD154) in human leukemic B-cells.

Authors:  Shaun Willimott; Simon D Wagner
Journal:  J Biol Chem       Date:  2011-12-02       Impact factor: 5.157

Review 4.  BH3-only proteins in apoptosis at a glance.

Authors:  Lina Happo; Andreas Strasser; Suzanne Cory
Journal:  J Cell Sci       Date:  2012-03-01       Impact factor: 5.285

Review 5.  Markers of platelet apoptosis: methodology and applications.

Authors:  Armen V Gyulkhandanyan; Asuman Mutlu; John Freedman; Valery Leytin
Journal:  J Thromb Thrombolysis       Date:  2012-05       Impact factor: 2.300

6.  BH3 mimetics antagonizing restricted prosurvival Bcl-2 proteins represent another class of selective immune modulatory drugs.

Authors:  Emma M Carrington; Ingela B Vikstrom; Amanda Light; Robyn M Sutherland; Sarah L Londrigan; Kylie D Mason; David C S Huang; Andrew M Lew; David M Tarlinton
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

Review 7.  The genetics of normal platelet reactivity.

Authors:  Thomas J Kunicki; Diane J Nugent
Journal:  Blood       Date:  2010-07-07       Impact factor: 22.113

8.  Determinants of platelet count in humans.

Authors:  Martina E Daly
Journal:  Haematologica       Date:  2011-01       Impact factor: 9.941

9.  Developmental Stage-Specific Manifestations of Absent TPO/c-MPL Signalling in Newborn Mice.

Authors:  Viola Lorenz; Haley Ramsey; Zhi-Jian Liu; Joseph Italiano; Karin Hoffmeister; Sihem Bihorel; Donald Mager; Zhongbo Hu; William B Slayton; Benjamin T Kile; Martha Sola-Visner; Francisca Ferrer-Marin
Journal:  Thromb Haemost       Date:  2017-12-06       Impact factor: 5.249

Review 10.  BCL-2 inhibition in AML: an unexpected bonus?

Authors:  Marina Konopleva; Anthony Letai
Journal:  Blood       Date:  2018-07-23       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.